Oxethazaine

CAS: 126-27-2

Ref. 3D-FO26625

Produktinformation

• Name: Oxethazaine
• Synonyme: 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)amino ethanolBetalgil, 2,2'-[(2-hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide], 2,2′-[(2-Hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide], 2,2′-[(2-Hydroxyethyl)imino]bis[N-(α,α-dimethylphenethyl)-N-methylacetamide], 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol, 2-[2-Hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide, Acetamide, 2,2′-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-, Acetamide, 2,2′-[(2-hydroxyethyl)imino]bis[N-(α,α-dimethylphenethyl)-N-methyl-, Betalgil, Fh 099, Mucoxin, N,N-bis(alpha,alpha-dimethylphenethyl)-N,N-dimethyl-2,2-(2-hydroxyethylimino)di(acetamide), Oxaine, Oxetacaine, Storocain, Storocaine, Topicain, Wy 806

Beschreibung

Oxethazaine is a drug that has been used to treat bowel disease and other diseases of the stomach and intestines. It belongs to the group of drugs called anticholinergic agents, which block the passage of nerve impulses in the intestine. The drug is also known for its ability to reduce inflammation and inhibit pain caused by autoimmune diseases. Oxethazaine is a potent inhibitor of fatty acid biosynthesis, which may be responsible for its therapeutic properties. This drug has not been extensively studied for its toxicity or pharmacokinetic properties.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 467.64 g/mol
• Formel: C₂₈H₄₁N₃O₃
• Reinheit: Min. 95%
• Farbe/Form: Powder